'hyperalaninémie'
(id=1836022 ; fe=hyperalaninémie ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=2441 creation date=2015-07-30 touchdate=2025-11-29 02:57:31.000) ≈ 159 relations sortantes
- hyperalaninémie --
r_associated #0: 44 / 1 ->
en:hyper-beta-alaninemia
n1=hyperalaninémie | n2=en:hyper-beta-alaninemia | rel=r_associated | relid=0 | w=44
- hyperalaninémie --
r_associated #0: 40 / 0.909 ->
acidose lactiqu e
n1=hyperalaninémie | n2=acidose lactiqu e | rel=r_associated | relid=0 | w=40
- hyperalaninémie --
r_associated #0: 40 / 0.909 ->
alanine
n1=hyperalaninémie | n2=alanine | rel=r_associated | relid=0 | w=40
- hyperalaninémie --
r_associated #0: 40 / 0.909 ->
ataxie cérébelleuse
n1=hyperalaninémie | n2=ataxie cérébelleuse | rel=r_associated | relid=0 | w=40
- hyperalaninémie --
r_associated #0: 40 / 0.909 ->
choréo-athétose
n1=hyperalaninémie | n2=choréo-athétose | rel=r_associated | relid=0 | w=40
- hyperalaninémie --
r_associated #0: 40 / 0.909 ->
citrullinémie
n1=hyperalaninémie | n2=citrullinémie | rel=r_associated | relid=0 | w=40
- hyperalaninémie --
r_associated #0: 40 / 0.909 ->
hyper-bêta-alaninémie
n1=hyperalaninémie | n2=hyper-bêta-alaninémie | rel=r_associated | relid=0 | w=40
- hyperalaninémie --
r_associated #0: 40 / 0.909 ->
hyperuricémie
n1=hyperalaninémie | n2=hyperuricémie | rel=r_associated | relid=0 | w=40
- hyperalaninémie --
r_associated #0: 40 / 0.909 ->
processus pathologique
n1=hyperalaninémie | n2=processus pathologique | rel=r_associated | relid=0 | w=40
- hyperalaninémie --
r_associated #0: 40 / 0.909 ->
pyruvate décarboxylase
n1=hyperalaninémie | n2=pyruvate décarboxylase | rel=r_associated | relid=0 | w=40
- hyperalaninémie --
r_associated #0: 28 / 0.636 ->
en:hyperalaninemia
n1=hyperalaninémie | n2=en:hyperalaninemia | rel=r_associated | relid=0 | w=28
- hyperalaninémie --
r_associated #0: 22 / 0.5 ->
hyperalaninémies
n1=hyperalaninémie | n2=hyperalaninémies | rel=r_associated | relid=0 | w=22
- hyperalaninémie --
r_associated #0: 20 / 0.455 ->
choréoathétose
n1=hyperalaninémie | n2=choréoathétose | rel=r_associated | relid=0 | w=20
- hyperalaninémie --
r_associated #0: 20 / 0.455 ->
E639
n1=hyperalaninémie | n2=E639 | rel=r_associated | relid=0 | w=20
- hyperalaninémie --
r_associated #0: 20 / 0.455 ->
en:alanine
n1=hyperalaninémie | n2=en:alanine | rel=r_associated | relid=0 | w=20
- hyperalaninémie --
r_associated #0: 20 / 0.455 ->
en:cerebellar ataxia
n1=hyperalaninémie | n2=en:cerebellar ataxia | rel=r_associated | relid=0 | w=20
- hyperalaninémie --
r_associated #0: 20 / 0.455 ->
en:citrullinemia
n1=hyperalaninémie | n2=en:citrullinemia | rel=r_associated | relid=0 | w=20
- hyperalaninémie --
r_associated #0: 20 / 0.455 ->
en:hyper-?-alaninemia
n1=hyperalaninémie | n2=en:hyper-?-alaninemia | rel=r_associated | relid=0 | w=20
- hyperalaninémie --
r_associated #0: 20 / 0.455 ->
en:hyperuricemia
n1=hyperalaninémie | n2=en:hyperuricemia | rel=r_associated | relid=0 | w=20
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
acide
n1=hyperalaninémie | n2=acide | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
en:hyodeoxycholic acid
n1=hyperalaninémie | n2=en:hyodeoxycholic acid | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyodésoxycholique
n1=hyperalaninémie | n2=hyodésoxycholique | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyodésoxycholique (acide)
n1=hyperalaninémie | n2=hyodésoxycholique (acide) | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyoïdien
n1=hyperalaninémie | n2=hyoïdien | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyper
n1=hyperalaninémie | n2=hyper | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyper-alpha-globulinémie
n1=hyperalaninémie | n2=hyper-alpha-globulinémie | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyper-bêta-globulinémie
n1=hyperalaninémie | n2=hyper-bêta-globulinémie | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyper-bêta-lipoprotéinémie
n1=hyperalaninémie | n2=hyper-bêta-lipoprotéinémie | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
Hyper-HDLémie
n1=hyperalaninémie | n2=Hyper-HDLémie | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyper-LDLémie
n1=hyperalaninémie | n2=hyper-LDLémie | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyperabsorbant
n1=hyperalaninémie | n2=hyperabsorbant | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyperacanthose
n1=hyperalaninémie | n2=hyperacanthose | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyperaction d'un muscle oculomoteur
n1=hyperalaninémie | n2=hyperaction d'un muscle oculomoteur | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyperactivité avec déficit de l'attention
n1=hyperalaninémie | n2=hyperactivité avec déficit de l'attention | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyperactivité détrusorienne
n1=hyperalaninémie | n2=hyperactivité détrusorienne | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyperactivité vésicale
n1=hyperalaninémie | n2=hyperactivité vésicale | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyperaldostéronisme
n1=hyperalaninémie | n2=hyperaldostéronisme | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyperaldostéronisme primaire
n1=hyperalaninémie | n2=hyperaldostéronisme primaire | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyperaldostéronisme secondaire
n1=hyperalaninémie | n2=hyperaldostéronisme secondaire | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyperaminoacidémie
n1=hyperalaninémie | n2=hyperaminoacidémie | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyperaminoacidurie
n1=hyperalaninémie | n2=hyperaminoacidurie | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyperammoniémie
n1=hyperalaninémie | n2=hyperammoniémie | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 15 / 0.341 ->
hyperammoniémie congénitale
n1=hyperalaninémie | n2=hyperammoniémie congénitale | rel=r_associated | relid=0 | w=15
- hyperalaninémie --
r_associated #0: 10 / 0.227 ->
bêta
n1=hyperalaninémie | n2=bêta | rel=r_associated | relid=0 | w=10
- hyperalaninémie --
r_associated #0: 10 / 0.227 ->
en:3,6-dihydroxy-5alpha-cholanoic acid
n1=hyperalaninémie | n2=en:3,6-dihydroxy-5alpha-cholanoic acid | rel=r_associated | relid=0 | w=10
- hyperalaninémie --
r_associated #0: 10 / 0.227 ->
en:deoxycholic acid
n1=hyperalaninémie | n2=en:deoxycholic acid | rel=r_associated | relid=0 | w=10
- hyperalaninémie --
r_associated #0: 10 / 0.227 ->
en:hyodeoxycholic acid, (3alpha,6beta)-isomer
n1=hyperalaninémie | n2=en:hyodeoxycholic acid, (3alpha,6beta)-isomer | rel=r_associated | relid=0 | w=10
- hyperalaninémie --
r_associated #0: 10 / 0.227 ->
en:hyodeoxycholic acid, sodium salt
n1=hyperalaninémie | n2=en:hyodeoxycholic acid, sodium salt | rel=r_associated | relid=0 | w=10
- hyperalaninémie --
r_associated #0: 10 / 0.227 ->
en:murideoxycholic acid
n1=hyperalaninémie | n2=en:murideoxycholic acid | rel=r_associated | relid=0 | w=10
- hyperalaninémie --
r_associated #0: 10 / 0.227 ->
en:nahdc compound
n1=hyperalaninémie | n2=en:nahdc compound | rel=r_associated | relid=0 | w=10
- hyperalaninémie --
r_associated #0: 10 / 0.227 ->
hyperactivité
n1=hyperalaninémie | n2=hyperactivité | rel=r_associated | relid=0 | w=10
- hyperalaninémie --
r_associated #0: 10 / 0.227 ->
médecine
n1=hyperalaninémie | n2=médecine | rel=r_associated | relid=0 | w=10
- hyperalaninémie --
r_associated #0: 6 / 0.136 ->
en:amino acid metabolism disorder
n1=hyperalaninémie | n2=en:amino acid metabolism disorder | rel=r_associated | relid=0 | w=6
- hyperalaninémie --
r_associated #0: 6 / 0.136 ->
en:seizure
n1=hyperalaninémie | n2=en:seizure | rel=r_associated | relid=0 | w=6
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
aldostérone
n1=hyperalaninémie | n2=aldostérone | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
aldostéronisme dû à une tumeur corticosurrénalienne
n1=hyperalaninémie | n2=aldostéronisme dû à une tumeur corticosurrénalienne | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
aldostéronisme primaire
n1=hyperalaninémie | n2=aldostéronisme primaire | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
angiotensine (test à l')
n1=hyperalaninémie | n2=angiotensine (test à l') | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
antialdostérones
n1=hyperalaninémie | n2=antialdostérones | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:abnormal ocular motility
n1=hyperalaninémie | n2=en:abnormal ocular motility | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:abnormal visual evoked potential
n1=hyperalaninémie | n2=en:abnormal visual evoked potential | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:abnormal visual evoked potential (vep)
n1=hyperalaninémie | n2=en:abnormal visual evoked potential (vep) | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:abnormality of ocular smooth pursuit
n1=hyperalaninémie | n2=en:abnormality of ocular smooth pursuit | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:adrenal gland hyperplasia
n1=hyperalaninémie | n2=en:adrenal gland hyperplasia | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:adrenal hyperplasia
n1=hyperalaninémie | n2=en:adrenal hyperplasia | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:adrenoleukodystrophy
n1=hyperalaninémie | n2=en:adrenoleukodystrophy | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:anisocoria
n1=hyperalaninémie | n2=en:anisocoria | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:anterior pituitary hypoplasia
n1=hyperalaninémie | n2=en:anterior pituitary hypoplasia | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:aspects of mortality statistics
n1=hyperalaninémie | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:aspects of radionuclide imaging
n1=hyperalaninémie | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:blindness
n1=hyperalaninémie | n2=en:blindness | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:c-cell hyperplasia
n1=hyperalaninémie | n2=en:c-cell hyperplasia | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:chemically induced
n1=hyperalaninémie | n2=en:chemically induced | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:complication aspects
n1=hyperalaninémie | n2=en:complication aspects | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:conn syndrome
n1=hyperalaninémie | n2=en:conn syndrome | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:cortical blindness (in 1 moroccan patient)
n1=hyperalaninémie | n2=en:cortical blindness (in 1 moroccan patient) | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:dermoid cyst
n1=hyperalaninémie | n2=en:dermoid cyst | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:diagnosis aspect
n1=hyperalaninémie | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:difficulty reading
n1=hyperalaninémie | n2=en:difficulty reading | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:dysmetric saccades
n1=hyperalaninémie | n2=en:dysmetric saccades | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:ectopic posterior pituitary
n1=hyperalaninémie | n2=en:ectopic posterior pituitary | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:end-position nystagmus
n1=hyperalaninémie | n2=en:end-position nystagmus | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:enzymology
n1=hyperalaninémie | n2=en:enzymology | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:epidemiologic
n1=hyperalaninémie | n2=en:epidemiologic | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:ethnologic
n1=hyperalaninémie | n2=en:ethnologic | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:etiology aspects
n1=hyperalaninémie | n2=en:etiology aspects | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:exposure as collected domain
n1=hyperalaninémie | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:eye
n1=hyperalaninémie | n2=en:eye | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:fatigue
n1=hyperalaninémie | n2=en:fatigue | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:genetic aspects
n1=hyperalaninémie | n2=en:genetic aspects | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:gliosis
n1=hyperalaninémie | n2=en:gliosis | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:hallucinations, visual, precipitated by infectious illness (in some patients)
n1=hyperalaninémie | n2=en:hallucinations, visual, precipitated by infectious illness (in some patients) | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:herpes zoster
n1=hyperalaninémie | n2=en:herpes zoster | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:historical aspects qualifier
n1=hyperalaninémie | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:horner syndrome
n1=hyperalaninémie | n2=en:horner syndrome | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:hypermetric saccades
n1=hyperalaninémie | n2=en:hypermetric saccades | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:immunology aspects
n1=hyperalaninémie | n2=en:immunology aspects | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:impaired horizontal smooth pursuit
n1=hyperalaninémie | n2=en:impaired horizontal smooth pursuit | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:in blood
n1=hyperalaninémie | n2=en:in blood | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:in cerebrospinal fluid
n1=hyperalaninémie | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:in urine
n1=hyperalaninémie | n2=en:in urine | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:infantile nystagmus
n1=hyperalaninémie | n2=en:infantile nystagmus | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:interictal downbeat nystagmus
n1=hyperalaninémie | n2=en:interictal downbeat nystagmus | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:lack of visual attention
n1=hyperalaninémie | n2=en:lack of visual attention | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:metabolic aspects
n1=hyperalaninémie | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:microbiological
n1=hyperalaninémie | n2=en:microbiological | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:mobius syndrome
n1=hyperalaninémie | n2=en:mobius syndrome | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:movement of visual image - finding
n1=hyperalaninémie | n2=en:movement of visual image - finding | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:nursing therapy
n1=hyperalaninémie | n2=en:nursing therapy | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:nutritional management
n1=hyperalaninémie | n2=en:nutritional management | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:nystagmus
n1=hyperalaninémie | n2=en:nystagmus | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:nystagmus, horizontal
n1=hyperalaninémie | n2=en:nystagmus, horizontal | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:nystagmus, jerky, horizontal, congenital
n1=hyperalaninémie | n2=en:nystagmus, jerky, horizontal, congenital | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:nystagmus, mild
n1=hyperalaninémie | n2=en:nystagmus, mild | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:oculomotor apraxia
n1=hyperalaninémie | n2=en:oculomotor apraxia | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:optic nerve hypoplasia
n1=hyperalaninémie | n2=en:optic nerve hypoplasia | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:pain
n1=hyperalaninémie | n2=en:pain | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:parasitology
n1=hyperalaninémie | n2=en:parasitology | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:parathyroid hyperplasia
n1=hyperalaninémie | n2=en:parathyroid hyperplasia | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:pathological aspects
n1=hyperalaninémie | n2=en:pathological aspects | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:pediatric adverse events terminology
n1=hyperalaninémie | n2=en:pediatric adverse events terminology | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:pediatric terminology
n1=hyperalaninémie | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:pharmacotherapeutic
n1=hyperalaninémie | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:photophobia
n1=hyperalaninémie | n2=en:photophobia | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:physiopathological
n1=hyperalaninémie | n2=en:physiopathological | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:pituitary agenesis
n1=hyperalaninémie | n2=en:pituitary agenesis | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:pituitary gland adenoma
n1=hyperalaninémie | n2=en:pituitary gland adenoma | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:pituitary hypoplasia (in some patients)
n1=hyperalaninémie | n2=en:pituitary hypoplasia (in some patients) | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:poor eye contact
n1=hyperalaninémie | n2=en:poor eye contact | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:primary aldosteronism
n1=hyperalaninémie | n2=en:primary aldosteronism | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:psychology qualifier
n1=hyperalaninémie | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:rehabilitation aspects
n1=hyperalaninémie | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:roentgenographic
n1=hyperalaninémie | n2=en:roentgenographic | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:secondary hyperaldosteronism
n1=hyperalaninémie | n2=en:secondary hyperaldosteronism | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:self-injury
n1=hyperalaninémie | n2=en:self-injury | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:sensorineural hearing loss
n1=hyperalaninémie | n2=en:sensorineural hearing loss | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:skin photosensitivity
n1=hyperalaninémie | n2=en:skin photosensitivity | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:spongiosis, mild
n1=hyperalaninémie | n2=en:spongiosis, mild | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:staring
n1=hyperalaninémie | n2=en:staring | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:supranuclear gaze palsy
n1=hyperalaninémie | n2=en:supranuclear gaze palsy | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:surgical aspects
n1=hyperalaninémie | n2=en:surgical aspects | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:taxonomic
n1=hyperalaninémie | n2=en:taxonomic | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:therapeutic aspects
n1=hyperalaninémie | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:thin pituitary stalk
n1=hyperalaninémie | n2=en:thin pituitary stalk | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:type 1 diabetes mellitus
n1=hyperalaninémie | n2=en:type 1 diabetes mellitus | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:type 2 diabetes mellitus
n1=hyperalaninémie | n2=en:type 2 diabetes mellitus | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:use of ultrasonography
n1=hyperalaninémie | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:viruses
n1=hyperalaninémie | n2=en:viruses | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:visual impairment
n1=hyperalaninémie | n2=en:visual impairment | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
en:visual inattention
n1=hyperalaninémie | n2=en:visual inattention | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
excès
n1=hyperalaninémie | n2=excès | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
globulinémie
n1=hyperalaninémie | n2=globulinémie | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
hyperaldostéronisme primaire à rénine basse
n1=hyperalaninémie | n2=hyperaldostéronisme primaire à rénine basse | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
hyperaldostéronismes
n1=hyperalaninémie | n2=hyperaldostéronismes | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
maladie
n1=hyperalaninémie | n2=maladie | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
maladie
(médecine)
n1=hyperalaninémie | n2=maladie (médecine) | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
maladies
n1=hyperalaninémie | n2=maladies | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
syndrome de conn
n1=hyperalaninémie | n2=syndrome de conn | rel=r_associated | relid=0 | w=5
- hyperalaninémie --
r_associated #0: 5 / 0.114 ->
syndrome de Conn
n1=hyperalaninémie | n2=syndrome de Conn | rel=r_associated | relid=0 | w=5
| ≈ 74 relations entrantes
- en:hyper-beta-alaninemia ---
r_associated #0: 114 -->
hyperalaninémie
n1=en:hyper-beta-alaninemia | n2=hyperalaninémie | rel=r_associated | relid=0 | w=114
- hyper-bêta-alaninémie ---
r_associated #0: 111 -->
hyperalaninémie
n1=hyper-bêta-alaninémie | n2=hyperalaninémie | rel=r_associated | relid=0 | w=111
- choréo-athétose ---
r_associated #0: 55 -->
hyperalaninémie
n1=choréo-athétose | n2=hyperalaninémie | rel=r_associated | relid=0 | w=55
- choréoathétose ---
r_associated #0: 52 -->
hyperalaninémie
n1=choréoathétose | n2=hyperalaninémie | rel=r_associated | relid=0 | w=52
- acidose lactiqu e ---
r_associated #0: 40 -->
hyperalaninémie
n1=acidose lactiqu e | n2=hyperalaninémie | rel=r_associated | relid=0 | w=40
- alanine ---
r_associated #0: 40 -->
hyperalaninémie
n1=alanine | n2=hyperalaninémie | rel=r_associated | relid=0 | w=40
- ataxie cérébelleuse ---
r_associated #0: 40 -->
hyperalaninémie
n1=ataxie cérébelleuse | n2=hyperalaninémie | rel=r_associated | relid=0 | w=40
- citrullinémie ---
r_associated #0: 40 -->
hyperalaninémie
n1=citrullinémie | n2=hyperalaninémie | rel=r_associated | relid=0 | w=40
- en:alanine ---
r_associated #0: 40 -->
hyperalaninémie
n1=en:alanine | n2=hyperalaninémie | rel=r_associated | relid=0 | w=40
- hyperuricémie ---
r_associated #0: 40 -->
hyperalaninémie
n1=hyperuricémie | n2=hyperalaninémie | rel=r_associated | relid=0 | w=40
- pyruvate décarboxylase ---
r_associated #0: 40 -->
hyperalaninémie
n1=pyruvate décarboxylase | n2=hyperalaninémie | rel=r_associated | relid=0 | w=40
- hyperalaninémies ---
r_associated #0: 39 -->
hyperalaninémie
n1=hyperalaninémies | n2=hyperalaninémie | rel=r_associated | relid=0 | w=39
- hyodésoxycholique (acide) ---
r_associated #0: 36 -->
hyperalaninémie
n1=hyodésoxycholique (acide) | n2=hyperalaninémie | rel=r_associated | relid=0 | w=36
- en:hyperuricemia ---
r_associated #0: 33 -->
hyperalaninémie
n1=en:hyperuricemia | n2=hyperalaninémie | rel=r_associated | relid=0 | w=33
- en:hyper-?-alaninemia ---
r_associated #0: 31 -->
hyperalaninémie
n1=en:hyper-?-alaninemia | n2=hyperalaninémie | rel=r_associated | relid=0 | w=31
- E639 ---
r_associated #0: 30 -->
hyperalaninémie
n1=E639 | n2=hyperalaninémie | rel=r_associated | relid=0 | w=30
- en:cerebellar ataxia ---
r_associated #0: 30 -->
hyperalaninémie
n1=en:cerebellar ataxia | n2=hyperalaninémie | rel=r_associated | relid=0 | w=30
- en:citrullinemia ---
r_associated #0: 28 -->
hyperalaninémie
n1=en:citrullinemia | n2=hyperalaninémie | rel=r_associated | relid=0 | w=28
- en:hyperalaninemia ---
r_associated #0: 26 -->
hyperalaninémie
n1=en:hyperalaninemia | n2=hyperalaninémie | rel=r_associated | relid=0 | w=26
- processus pathologique ---
r_associated #0: 26 -->
hyperalaninémie
n1=processus pathologique | n2=hyperalaninémie | rel=r_associated | relid=0 | w=26
- en:hyodeoxycholic acid ---
r_associated #0: 25 -->
hyperalaninémie
n1=en:hyodeoxycholic acid | n2=hyperalaninémie | rel=r_associated | relid=0 | w=25
- en:hyperaldosteronism ---
r_associated #0: 23 -->
hyperalaninémie
n1=en:hyperaldosteronism | n2=hyperalaninémie | rel=r_associated | relid=0 | w=23
- en:hyperuricaemia ---
r_associated #0: 22 -->
hyperalaninémie
n1=en:hyperuricaemia | n2=hyperalaninémie | rel=r_associated | relid=0 | w=22
- hyperaldostéronisme ---
r_associated #0: 22 -->
hyperalaninémie
n1=hyperaldostéronisme | n2=hyperalaninémie | rel=r_associated | relid=0 | w=22
- Pyruvate décarboxylase ---
r_associated #0: 20 -->
hyperalaninémie
n1=Pyruvate décarboxylase | n2=hyperalaninémie | rel=r_associated | relid=0 | w=20
- ALanine ---
r_associated #0: 15 -->
hyperalaninémie
n1=ALanine | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- Alajouanine (manoeuvre d') ---
r_associated #0: 15 -->
hyperalaninémie
n1=Alajouanine (manoeuvre d') | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- Alanine ---
r_associated #0: 15 -->
hyperalaninémie
n1=Alanine | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- Atad (sonde cervico-utérine d') ---
r_associated #0: 15 -->
hyperalaninémie
n1=Atad (sonde cervico-utérine d') | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- Hyper-HDLémie ---
r_associated #0: 15 -->
hyperalaninémie
n1=Hyper-HDLémie | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyoïdien ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyoïdien | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyper-LDLémie ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyper-LDLémie | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyper-alpha-globulinémie ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyper-alpha-globulinémie | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyper-bêta-globulinémie ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyper-bêta-globulinémie | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyper-bêta-lipoprotéinémie ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyper-bêta-lipoprotéinémie | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyperabsorbant ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyperabsorbant | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyperacanthose ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyperacanthose | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyperaction d'un muscle oculomoteur ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyperaction d'un muscle oculomoteur | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyperactivité avec déficit de l'attention ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyperactivité avec déficit de l'attention | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyperactivité détrusorienne ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyperactivité détrusorienne | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyperactivité vésicale ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyperactivité vésicale | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyperaldostéronisme primaire ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyperaldostéronisme primaire | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyperaldostéronisme secondaire ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyperaldostéronisme secondaire | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyperaminoacidurie ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyperaminoacidurie | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyperaminoacidémie ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyperaminoacidémie | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyperammoniémie ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyperammoniémie | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- hyperammoniémie congénitale ---
r_associated #0: 15 -->
hyperalaninémie
n1=hyperammoniémie congénitale | n2=hyperalaninémie | rel=r_associated | relid=0 | w=15
- Hyperaldostéronisme ---
r_associated #0: 10 -->
hyperalaninémie
n1=Hyperaldostéronisme | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- dysplasie rénale, dystrophie rétinienne pigmentaire, ataxie cérébelleuse et dysplasie squelettique ---
r_associated #0: 10 -->
hyperalaninémie
n1=dysplasie rénale, dystrophie rétinienne pigmentaire, ataxie cérébelleuse et dysplasie squelettique | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:ADHD ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:ADHD | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:Atad's catheter ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:Atad's catheter | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:Doll's eye movement ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:Doll's eye movement | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:acanthosis ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:acanthosis | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:attention deficit hyperactivity disorder ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:attention deficit hyperactivity disorder | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:congenital hyperammonaemia ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:congenital hyperammonaemia | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:hyper attenuation ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:hyper attenuation | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:hyper-?-globulinaemia ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:hyper-?-globulinaemia | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:hyper-?-lipoproteinemia ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:hyper-?-lipoproteinemia | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:hyperHDLemia ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:hyperHDLemia | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:hyperLDLemia ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:hyperLDLemia | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:hyperacanthosis ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:hyperacanthosis | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:hyperalphaglobulinemia ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:hyperalphaglobulinemia | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:hyperaminoacidaemia ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:hyperaminoacidaemia | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:hyperaminoaciduria ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:hyperaminoaciduria | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:hyperammoniaemia ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:hyperammoniaemia | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:hyperuricemia. ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:hyperuricemia. | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:overaction of oculomotor muscle ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:overaction of oculomotor muscle | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:primary hyperaldosteronism ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:primary hyperaldosteronism | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- en:secondary hyperaldosteronism ---
r_associated #0: 10 -->
hyperalaninémie
n1=en:secondary hyperaldosteronism | n2=hyperalaninémie | rel=r_associated | relid=0 | w=10
- Hyperuricémie ---
r_associated #0: 5 -->
hyperalaninémie
n1=Hyperuricémie | n2=hyperalaninémie | rel=r_associated | relid=0 | w=5
- alamandine ---
r_associated #0: 5 -->
hyperalaninémie
n1=alamandine | n2=hyperalaninémie | rel=r_associated | relid=0 | w=5
- ataxie ---
r_associated #0: 5 -->
hyperalaninémie
n1=ataxie | n2=hyperalaninémie | rel=r_associated | relid=0 | w=5
- ataxie aigüe de Leyden-Westphal ---
r_associated #0: 5 -->
hyperalaninémie
n1=ataxie aigüe de Leyden-Westphal | n2=hyperalaninémie | rel=r_associated | relid=0 | w=5
- en:overactive bladder (OAB) ---
r_associated #0: 5 -->
hyperalaninémie
n1=en:overactive bladder (OAB) | n2=hyperalaninémie | rel=r_associated | relid=0 | w=5
|